US pharma major Eli Lilly (NYSE: LLY) has expanded its partnership with US biotech company Gate Bioscience to develop oral ...

TRex Bio, the US clinical-stage immunology company built on regulatory T cell (Treg) biology, has set terms for a Nasdaq initial public offering of 8,333,334 shares priced at $14 to $16 each, under ...

US pharma major AbbVie and Denmark’s Genmab late yesterday announced positive top-line results from the Phase III EPCORE ...

During the week spanning September 30 to October 6, a half-dozen pharmaceutical products debuted in fresh territories. Within the United States, Celcuity introduced its oncology medication, Revtorpyk ...

Shares of Vaxcyte, a US clinical-stage vaccine innovation company, rocketed as much as 90% in pre-market activity today ...

An Expert View from Joel Stanley, CEO of AJNA BioSciences, a company developing botanical medicines from cannabis and ...

Australia’s CSL Limited and Swiss clinical-stage biotech Alentis Therapeutics today announced an exclusive global ...

Danish pharma major Novo has reported results from REVEAL-1, which it describes as the largest UK real-world study of Wegovy ...

Jiangsu Nhwa Pharmaceutical, the Chinese CNS-focused pharma company, has granted newly-formed US biotech Somnivera exclusive ...

Chinese drugmaker Hansoh Pharmaceutical (HKEX: 3692) plans to resubmit its lung cancer drug Aumseqa (aumolertinib) for ...

Patients taking part in a clinical trial may be able to have blood drawn at home, speak to the study doctor by video and ...

Swedish immuno-oncology firm Alligator Bioscience has announced the appointment of Johan Giléus as Alligator’s new chief ...